2-氧代-2-[1-(3-吡啶甲基氨基)-1''''-芳基]甲基-4-芳基-5,5-二甲基-1,3,2-二氧磷杂环己烷的合成与生物活性

采用环状亚磷酸酯与亚胺的加成反应, 合成了9个未见文献报道的含吡啶基的α-氨基环状膦酸酯化合物. 其结构经1H NMR, 31P NMR, MS 和元素分析确证, 同时采用X射线单晶衍射对化合物3i的立体构型进行了进一步确证. 测定了该系列化合物的杀虫、杀菌和除草活性, 结果表明, 化合物的杀虫活性虽然较差, 但所有化合物在药液质量浓度为1.0×10-4 g/mL时都具有较好的除草活性, 部分化合物在5.0×10-5 g/mL时显示出良好的杀菌活性.     

2-氧代-2-[1-(3-吡啶甲基氨基)-1′-芳基]甲基-4-芳基-5,5-二甲基-1,3,2-二氧磷杂环己烷的合成与生物活性

采用环状亚磷酸酯与亚胺的加成反应,合成了9个未见文献报道的含吡啶基的α-氨基环状膦酸酯化合物.其结构经1H NMR,31P NMR,MS和元素分析确证,同时采用X射线单晶衍射对化合物3i的立体构型进行了进一步确证.测定了该系列化合物的杀虫、杀菌和除草活性,结果表明,化合物的杀虫活性虽然较差,但所有化合物在药液质量浓度为1.0×10-4g/mL时都具有较好的除草活性,部分化合物在5.0×10-5g/mL时显示出良好的杀菌活性.     

反式-2-取代硫代氨基脲基-4-芳基-5,5-二甲基-2-氧-1,3,2-二氧磷杂环己烷的立体选择性合成及立体化学研究

首先合成了重要的磷酰异硫氰酸酯中间体3, 然后便捷、高产率且立体选择性地合成了反式-2-取代硫代氨基脲基取代的新型六元磷杂环, 其立体化学通过2D NOESY NMR确证. 所有合成的化合物均进行了元素分析和光谱表征, 其中目标产物的13C NMR表征为1,3,2-二氧磷杂环己烷衍生物的碳骨架表征提供了难得的依据. 在溶剂DMSO-d6中, 所有产物均异构化, 生成磷原子的差向异构体. 这一研究结果证明了C4—H 以及31P NMR谱图与立体结构的相关性.     

2-苯羟甲基-5,5-二甲基-4-苯基-2-氧代1,3,2-二氧磷杂环己烷的合成及表征

以苯甲醛、异丁醛、三氯化磷为原料合成了新型的1,3,2-二氧磷杂环类化合物2-苯羟甲基-5,5-二甲基-4-苯基-2-氧代-1,3,2-二氧磷杂环己烷,总收率为40．8％,并对其进行了NMR研究和结构表征。     

不对称1,3,2-苯并二氧磷杂环己烷非对映消旋体的合成及生物活性

通过相转移催化关环反应合成了新的6-取代-2-疏-2-烷(芳)氧-4-(2,-4二氯苯基)-4-氢-1,3,2-苯并二氧磷杂环已烷(3a-3g),用结晶法分离得到7对非对联消旋体,其结构经¹HNMR、³¹PNMR和元素分析确证,化合物3a-A单晶X射线分析表明其构型为(2R,4S;2S,4R).生物活性测定结果表明,化合物3C有良好的杀虫活性,非对映消旋体A和B具有协同杀虫作用.     

乙交酯与2-氢-2-氧-1,3,2-二氧磷杂环己烷的开环共聚研究

聚乙醇酸及其与乳酸的共聚物是一类无毒、有良好的生物相容性和生物可降解材料,它们广泛地用作药物控释体系的载体,牙科植入材料［１,２］．但由于聚乙醇酸的高度可结晶性,使其不溶于包括三氟乙酸在内的几乎所有的有机溶剂,因此通过共聚来改进其物化性质的研究一直方...     

2-氧代-2-[(2-氯-5-吡啶甲氨基)(芳基)甲基]-4-芳基-5,5-二甲基-1,3,2-二氧膦杂环己烷的合成及其生物活性研究

通过类Mannich 反应“一锅法”合成了10个未见文献报道的含吡啶基的环状α-氨基膦酸酯, 其结构经¹H NMR, ³¹P NMR, IR, MS和元素分析确证. 测定了该系列化合物的杀虫、杀菌和除草活性, 结果表明, 所测化合物的杀虫活性不太好, 但所有化合物在药液浓度为1.0×10^－4 g/mL 时都具有较好的除草活性, 部分化合物在5.0×10^－5 g/mL时显示出良好的杀菌活性.     

5,5-二甲基-2-氧代-2-(N,N-对苯二胺基-二苄基)-二-1,3,2-氧磷杂环己烷的合成及表征

以新戊二醇、三氯化磷和乙醇为原料制得中间体 5 ,5 -二甲基 -1 ,3,2 -二氧磷杂环己烷 -2 -氧 ( DPDO) ,用DPDO与由芳醛和对苯二胺缩合制得的席夫碱 SB ～ SB 加成 ,合成了膨胀型阻燃剂 5 ,5 -二甲基 -2 -氧代 -2 -( N,N -对苯二胺基 -二苄基 ) -二 -1 ,3,2 -氧磷杂环己烷 ( DPPO ～ DPPO ) ,通过元素分析 ,IR,NMR和 MS对其结构进行表征 ,并对其在醇酸清漆中的应用进行了讨论     

DL－丙交酯与2－氢－2－氧－1，3，2－二氧磷杂环己烷的开环共聚合研究

在三异丁基铝催化下ＤＬ－丙交酯与２－氢－２－氧－１，３，２－二氧磷杂环己烷开环共聚，制备了一类新型水溶性共聚物Ｐ（ＬＡ－ｃｏ－ＴＭＰ）。用１ＨＮＭＲ、ＩＲ谱对其结构进行了表征，并研究了催化剂用量及不同单体配比对总转化率、共聚物组成及特性粘度的影响。     

3，6-双（3’-氨基呋咱-4-基）-1，4-二氧杂-2，5-二氮杂环己-2，5-二烯的合成及晶体结构

以3-氨基-4-酰胺肟基呋咱（AAOF）为原料合成出了含能化合物3-氨基-4-酰氯肟基呋咱（ACOF）。用稀碱3％～5％Na2CO3水溶液处理，ACOF脱去一分子HCl生成不稳定中间体3-氨基-4-氰基呋咱的氧化物（ACFO），随后发生歧化反应，生成3，4-二（氨基呋咱基）氧化呋咱（BAFF）及其异构体3，6-双（3’-氨基呋咱-4-基）-1，4-二氧杂-2，5-二氮杂环己-2，5-二烯（BADDD）。用IR、MS、^1H NMR、^13C NMR和元素分析对ACOF的分子结构进行了表征。分子和晶体结构测试表明，BADDD是一具有新颖化学分子结构的化合物。     

Synthesis and Biological Activity of Cis 2-(6-Chloropyridine-3-yl)methylamino-4-substitutedphenyl-5,5-dimethyl-1,3,2-dioxaphosphinane 2-Oxides

A series of novel, asymmetric-cyclic phosphoramides containing substituted pyridine were synthesized via the condensation reactions of trans 2-chloro-4-substitutedphenyl-5, 5-dimethyl-1,3,2-dioxaphosphinane 2-oxide with 2-chloro-5-aminomethylpyridine or 3-aminomethylpyridine. The reactions show good stereoselectivity. Only the cis isomer from configuration inversion was obtained, which is the thermodynamic stable product. The structures of the products were characterized by ¹H NMR, ³¹P NMR, IR, MS, and elemental analysis. The configuration of the product was determined by X-ray diffraction analysis. The results of preliminary bioassay showed that the new compounds possess potential insecticidal and fungicidal activities.     

Synthesis and Crystal Structure of Cis 2-（6-Chloro-3-pyridylmethylamino）-4-chlorophenyl- 5,5-dimethyl- 1,3,2-dioxaphosphinane 2-Oxides

1 INTRODUCTION Neonicotinioid insecticides as nicotinic acetyl-choline receptor inhibitors have attracted increasingattention because of its safety, low toxicity, wide andhigh activities[1, . A lot of new insecticides such as 2]imidacloprid, acetamiprd and nitenpyram have beencommercialized. It is found that most biologicallyactive nicotinic compounds contain 3-aminomethyl-pyridine moiety[3]. Due to their wide biological acti-vities, organic phosphorus heterocyclic compoundsplay an import…     

Synthesis, Dimeric Crystal Structure, and Biological Activities of N-(4-Methyl-6-oxo-1,6-dihydro-pyrimidin-2-yl)-N-(2-trifluoromethyl-phenyl)-guanidine

The title compound, N-(4-methyl-6-oxo-1,6-dihydro-pyrimidin-2-yl)-N′-(2-trifluoromethyl-phenyl)-guanidine, was synthesized and its structure was confirmed by using IR, MS, 1H NMR, and elemental analysis. The single crystal structure of the title compound was determined by X-ray diffraction. The preliminary biological test showed that the synthesized compound has a weak herbicidal activity.     

Synthesis, Dimeric Crystal Structure, and Biological Activities of N- （ 4-Methyl-6-oxo-1,6-dihydro-pyrimidin-2-yl ） -N＇- （ 2-trifluoromethyl-phenyl ） -guanidine

The title compound, N-（4-methyl-6-oxo-1,6-dihydro-pyrimidin-2-yl）-N＇-（2-tritluoromethyl-phenyl）-guanidine, was synthesized and its structure was confirmed by using IR, MS,^1H NMR, and elemental analysis. The single crystal structure of the title compound was determined by X-ray diffraction. The preliminary biological test showed that the synthesized compound has a weak herbicidal activity.     

Unusual behavior of 3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one towards some phosphorus reagents: Synthesis of novel diethyl 2-phosphonochromone,diethyl 3-phosphonopyrone and 1,3,2-oxathiaphosphinines

The chemical reactivity of 3-(dimethylamino)-1-(2-hydroxyphenyl)prop-2-en-1-one (1) towards some phosphorus reagents was studied. The enaminone 1 was cyclized into diethyl 2-phosphonochromone 2 via its treatment with diethyl phosphite in basic medium. However, its reaction with triethoxy phosphonoacetate gave the substituted pyrone phosphonate 3. In addition, two novel examples of 4-(dimethylamino)-6-(2-hydroxyphenyl)-2-sulfido-4H-1,3,2-oxathia-phosphinines 6 and 7 were obtained from treatment of enaminone 1 with O,O-diethyl dithiophosphoric acid and Lawesson’s reagent. When enaminone 1 was also treated with phosphorus decasulfide, it was turned into 4H-thiochromene-4-thione while its treatment with phosphorus tribromide, phosphorus oxychloride, or phenylphosphonic dichloride, 4H-4-oxo-chromene was isolated in all cases. The possible reaction mechanisms of the formation of these products were discussed. The structures of newly isolated products were established by elemental analysis and spectral tools.     

Synthesis, Crystal Structure and Biological Activity of 2-Chloro-N-{2-fluoro-5-[N-(phenylsulfonyl) phenyl- sulfonamido] phenyl} benzamide

2-Chloro-N-{2-fluoro-5-[N-(phenylsulfonyl)phenylsulfonamido]phenyl}benzamide was synthesized and its crystal structure was also determined by X-ray single-crystal diffraction. The title compound(C25H18C1FN2O5S2) belongs to monoclinic, space group P21/n with a=0.7377(3) nm, b=1.2036(5) nm, c=2.6846(11) nm, β=90.895(9)°,V=2.3833(16) nm3, Mr=544.98, Z=4, Dc= 1.519 g/cm3, μ=0.385 mm-1, F(000)=1120, R1=0.0632, and wR2=0. 1438. Its crystal structure belongs to a novel class that has not been reported yet, and its preliminary herbicidal activity was also tested. Its inhibition rate to seedling growth of barnyard grass reaches 15.1% at 100 μg/mL.     

Synthesis and Crystal Structure of 5,5-Dimethyl-2-(4-chlorophenyl)(3-hydroxy-5,5-dimethyl-2-cyclohexen-1-one-2-yl)methyl-3-(4-methoxyphenylamino)-2-cyclohexene-1-one

The title compound 5,5-dimethyl-2-(4-chlorophenyl)(3-hydroxy-5,5-dimethyl-2-cyclohexen-1-one-2-yl)methyl-3-(4-methoxyphenylamino)-2-cyclohexen-1-one has been synthesized,and its crystal structure was characterized by X-ray single-crystal diffraction. The crystal belongs to monoclinic,space group P21/c with a=9.4193(13),b=26.915(4),c=21.188(3),β =101.906(3)°,V =5256.2(13)3,Z =4,C60H68Cl2N2O8,Mr=1016.06,Dc=1.284 g/cm3,F(000)=2160,λ(MoKα)=0.71073,μ=0.182 mm–1,R=0.0530 and wR=0.1131 for 4128 observed reflections (I>2σ(I)). X-ray analysis reveals that there are two independent molecules in the unit and the cyclohexenone rings adopt different conformations. In addition,there are four intramolecular hydrogen bonds in the title molecule.